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SUMMARY  
Clinicians sometimes are confronted with the challenge 
of transfusing haemorrhaging Rhesus (Rh) D negative 
patients with Rh D positive blood to save their lives. 
There are concerns about alloimmunization and future 
haemolytic disease of the newborn in women of the 
reproductive age. Another fear is transfusion reaction if 
they receive another Rh D positive blood in future. We 
present a 32-year-old Rh D negative woman, who had 
postpartum haemorrhage in her first pregnancy and was 
transfused with Rh D positive blood because of una-
vailability of Rh D negative blood. She did not receive 
anti D immunoglobin but subsequently had a normal 
term pregnancy of an Rh positive fetus without any 
detectable anti D antibodies throughout the pregnancy. 
In life threatening situations from obstetric haemor-
rhage, transfusion of Rh D negative women with Rh D 
positive blood should be considered as the last resort. 
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INTRODUCTION  
Clinicians sometimes are confronted with the challenge 
of transfusing Rhesus (Rh) D negative patients with Rh 
D positive blood under critical conditions to save life. 
This is more so in women of the reproductive age be-
cause of the fear of Rhesus alloimmunization and sub-
sequent haemolytic disease of the newborn. Another 
concern is future transfusion reaction if they receive Rh 
D positive blood transfusion again.  
 
These concerns may lead to delay in transfusing Rh D 
negative patients with Rh D positive blood, which can 
result in severe morbidity or even death. About 20% of 
volunteer Rh D individuals given 500ml of Rh D posi-
tive blood will not seroconvert1 and for individuals 




We present a 32-year-old Rh D negative para 2 woman 
with a prior Rh D positive blood transfusion without 
anti D immunoglobin. She had a subsequent normal 
term pregnancy with no detectable anti D antibodies 
throughout the pregnancy. She was managed at the 
Regional Hospital, Ridge-Accra.  
 
The aim of this paper is to share our experience with 
other health care providers. 
 
Case report 
Madam VD 32 years, G2 P2 was first seen at the Ridge 
Hospital Accra, on 26/5/12. She had been referred from 
a polyclinic as a case of primary postpartum haemor-
rhage (PPH) due to retained placenta. She had had a 
spontaneous vaginal delivery at 5.40am and arrived at 
the Ridge hospital at 8.30am.  
 
The estimated blood loss according to her medical rec-
ords was 500ml. Treatments given before referral in-
cluded intramuscular oxytocin 10IU, intravenous fluid 
(IVF) 1000ml Ringers lactate and 500ml Normal sa-
line. Her vital signs recorded at the time of referral 
were: temperature 36oC, blood pressure (BP) 80/40 
mmHg. No records on her pulse and respiratory rate 
(RR) were given. The baby was a 2.6kg male with Ap-
gar scores of 7 at 1 minute and 8 at 5 minutes. Besides 
the information in the referral, we had no more details 
of her medical records.  
 
On arrival at the Ridge hospital, she was unconscious 
and her clothing was heavily soaked with blood. Her 
conjunctiva was very pale; she was not cyanosed or 
jaundiced. She had deep sighing respiration with a RR 
of 14 cycles/minute and the chest was clinically clear. 
The pulse and BP were unrecordable.  
 
The uterus was 24 weeks (wk.) size and flabby. Digital 
vaginal examination showed the cervix was 5cm dilat-










A urethral catheter was in situ but there was no urine in 
the bag. She had one IV line on but the fluid had fin-
ished. We estimated that she had lost at least 2000ml of 
blood. 
 
Resuscitation was started with crystalloids and oxygen 
was given by face mask. A second IV line was set up 
and blood for grouping and cross matching was taken. 
Manual removal of the placenta was done and about 
200ml of blood clots were also expelled from the uter-
us. Intravenous ergometrine 0.5mg was given and 
600µg misoprostol was inserted rectally. There was no 
further bleeding per vaginum thereafter. The haemo-
globin (Hb) checked with URIT – 12 Hemoglobin me-
ter was below the detection level of the machine, which 
is 4.0g/dl (URIT Medical Electronics, Guangxi, Chi-
na). 
 
A request was made for one unit of group specific un-
cross matched blood while waiting for the cross match-
ing. Her blood group turned out to be O Rh D negative 
but there was no O negative blood available. A request 
was made for uncross matched O Rh D positive blood 
and she was transfused with 500ml of it. She later had 
three units of O Rh D negative blood transfused over 
the next 18 hours. This was her first blood transfusion. 
She did not receive anti D immunoglobin because of 
financial constraints. She produced about 800ml of 
urine over the next 24 hours. She was covered with 
broad-spectrum antibiotics.  
 
She developed both retrograde and anterograde amne-
sia. It took 48 hours for her to remember her name and 
could also not recount what happened within the first 
24 hours of admission. She was discharged home on 
the 7th day with an Hb of 7.5g/dl. She was given oral 
haematinics. She was counselled on the fact that the 
incompatible Rh D positive blood transfusion could 
lead to sensitization and subsequent transfusion reac-
tion in case of future Rh D positive blood transfusion. 
In addition future children may suffer from haemolytic 
disease of the newborn.  
 
It was therefore important for her to inform her health 
care providers about the incompatible blood transfu-
sion wherever she will be. Both the obstetricians and 
the neurosurgeon followed her up for the first six 
weeks. Further follow-ups were done by the neurosur-
geon alone for another six weeks. At the twelve-week 
review, she was given a four-week appointment but did 
not turn up.  
                                                                                                                                                                                                                                                                                                                                                                                                                                    
History of current pregnancy 
The next time she was heard of was when she called 
the lead author to inform him that she was three 
months pregnant and want to start antenatal care. She 
was first seen on 2/4/13. On examination, she looked 
well and her general condition was satisfactory. Her 
pulse rate was 78 beats/min with a BP of 
110/80mmHg. The uterus was about 14 weeks’ size 
pregnancy.  
 
A diagnosis of Pregnancy in a Rhesus D negative 
woman with prior Rh D Positive blood transfusion was 
made. Laboratory investigations requested and the re-
ports were as follows: 
Hb - 14.0g/dl, Sickling –Negative, Blood group - O 
Rhesus D Negative, VDRL - Non reactive, Hepatitis B 
surface antigen screen - Negative, G6PD screen- No 
defect, Indirect antiglobulin (Coombs) test- Negative, 
HIV I&II screen-Non Reactive, Stool and urine routine 
exams- Normal,  
 
An obstetric ultrasound scan done on 25/4/13 reported 
of a single viable intrauterine pregnancy, normal liquor 
volume, posterior placenta, the average gestational age 
was 16 wk 2days and the expected date of delivery was 
9/10/2013.  
 
Subsequent care: The antenatal period remained une-
ventful. She received intermittent preventive treatment 
for malaria, tetanus toxoid and oral haematinics. Fur-
ther indirect Coombs tests done at 28, 31, 34 and 38wk 
were all negative. Two subsequent obstetric scans done 
showed normal fetal growth with no abnormalities. The 
Hb was 12.8g/dl at 38wk.  
  
At 38wk 3 days of gestation, she went into spontaneous 
labour. The cervical dilatation remained 4cm after 
10hours despite oxytocin augmentation and was deliv-
ered by caesarean section. The baby was a female, 
weighed 3.0kg with Apgar scores of 8 and 9 at 1 and 5 
minutes respectively.  
 
The baby’s blood group was A Rh D positive. The 
mother received a single dose of Anti D immunoglobu-
lin (300µg). The baby was monitored clinically for 4 
weeks and she did not develop neonatal jaundice. 
 
DISCUSSION 
Obstetric haemorrhage is a leading cause of maternal 
mortality in Ghana3 and getting sufficient Rh D nega-
tive blood in time for the haemorrhaging Rh D negative 
parturient can be a challenge.  
 
Among the blood group systems, the Rh system is the 
most complex and the D antigen is second to the ABO 
in terms of immunogenicity4. Generally, individuals 
who are Rh D negative do not express the RHD gene.5  
 
 






However some Africans and Japanese with Rh D nega-
tive phenotype have the RHD gene.6,7  Some individu-
als also express a very limited amount of the D antigen 
and are classified as weak D.  
 
These individuals are actually Rh D positive and are 
not likely to produce anti D antibodies when exposed 
to Rh D positive blood.8 They can safely be transfused 
with Rh D positive blood without receiving anti D im-
munoglobin.8, 9 
 
The incidence of Rh D negative among blood donors in 
Kumasi, Ghana is 8%. Among the donors were 31 Rh 
D negative individuals with 6.4% of them being weak 
D. None of the weak Ds were females which could be 
due to the small number of females; only six.10 This 
brings to the fore the need to further investigate indi-
viduals who are found to be Rh D negative by the rou-
tine serological test to identify those who are weak D 
before labeling all of them as Rh D negative.  
 
At the first exposure to Rh D positive blood, Rh D 
negative individuals who will seroconvert produce 
small amounts of IgM albeit transient. With a second 
exposure the reaction is rapid with the production of 
IgG and as little as 0.03ml of Rh D positive red blood 
cells (RBC) can elicit a secondary response.4 
 
Madam VD was transfused with Rh D positive blood 
because she was in a critical state and no O Rh D nega-
tive blood was immediately available. At presentation 
she was in shock, had air hunger (deep sighing slow 
RR of 14) and anuria. We estimated the total blood loss 
to be at least 2000ml as it has been established that 
patients with obstetric haemorrhage in this state have 
lost between 2000ml to 3000ml of blood.11 
 
To prevent alloimmunization, she should have been 
given anti D immunoglobin. About 20µg of anti D im-
munoglobin is needed per 1ml of Rh D positive RBCs1. 
About 220ml of packed RBCs are contained in 500ml 
of whole blood12 which means Madam VD required 
4400µg which she could not afford. We gave her anti 
D immunoglobin in the index pregnancy because we 
do not know why she did not seroconvert after the 
blood transfusion.  
 
One of the possible explanations for her failure to sero-
convert could be that she has a weak D. Factors that 
can affect the determination of one’s Rh D status in-
clude the type of method used and type of monoclonal 
antibodies in the reagent which may have differential 
reactivity with the different D antigen variants8,13 The 
routine serological test use to determine the Rh D fac-
tor for blood typing would identify weak D as D nega-
tive.14 RHD polymerase chain reaction (PCR), a facili-
ty which our hospital lack is needed to detect weak D.12 
Even if the facility exists, it is not practical to use in 
such emergencies. Moreover, there are limitations with 
the PCR as some Africans and Japanese with Rh D 
negative phenotype have the RHD gene.6,7  
 
Assuming Madam VD is actually true Rh D negative; 
other factors could explain why she did not serocon-
vert. The ability for an individual to produce antibodies 
to a given antigen depends on the individual’s immune 
response, the amount of antigen exposed to, the route 
of administration and the immunogenicity of the anti-
gen.4 
 
Polymorphism of the immune response genes affects 
an individual’s ability to produce antibodies15. HLA-
antigens are crucial for cell to cell interaction in anti-
body production and high anti-D titers, have been 
linked to certain HLA-DR types.16 Thus an individual’s 
genetic predisposition may prevent the one from pro-
ducing antibodies if exposed to a given antigen.17 
  
With regards to its immunogenicity and volume needed 
to cause sensitization, the D antigen is very immuno-
genic and parenteral administration of Rh D positive 
RBC volumes as little as 0.1ml is capable of causing 
sensitization in Rh D negative individuals.18 Hence the 
about 220ml Rh D positive RBCs received by Madam 
VD was enough to cause sensitization. 
 
Dutton et al19 observed a decrease in seroconversion in 
Rh D negative patients in shock who were transfused 
with Rh D positive blood and suggested that this might 
be due to the immunosuppression associated with 
haemorrhagic shock. This could also explain why 
Madam VD did not seroconvert.  
 
Our management of Madam VD had two limitations. 
The first was our inability to rule out weak D which 
was due to lack of the facility to do that. The second is 
the fact that the detection of anti D antibodies were 
done only by the indirect Coombs test technique. This 
technique is less sensitive than the enzyme test using 
papain.20 Clinically however, the most important indi-
cator for primary sensitization is the production of an-
tibodies in subsequent pregnancies.21 Even in cases 
where the primary response is weak, the secondary 
response is vigorous and failure of a secondary re-
sponse is the ultimate proof of failure of primary im-
munization.20  
Madam VD’s second child is RH D positive. Feto-
maternal haemorrhage in pregnancy is almost univer-
sal22 and very small volumes of blood could elicit a 
secondary immune response4.  
 
 






We therefore anticipated that if Madam VD was sensi-
tized she would have produced antibodies as the preg-
nancy progressed. The failure to detect anti D antibod-
ies may be the proof of non-immunization on her part. 
 
CONCLUSION  
Rhesus alloimmunization is not automatic when Rh D 
negative individuals in shock are transfused with Rh D 
positive blood. In life threatening situations from ob-
stetric haemorrhage, transfusion of Rh D negative 
women with Rh D positive blood should be considered 
as the last resort.  
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